T1	AdverseReaction 153 186	immune-mediated adverse reactions
T2	AdverseReaction 147 152	fatal
T3	Severity 136 142	severe
T4	AdverseReaction 363 376	enterocolitis
T5	AdverseReaction 378 387	hepatitis
T6	AdverseReaction 389 399	dermatitis
T7	AdverseReaction 411 437	toxic epidermal necrolysis
T8	AdverseReaction 440 450	neuropathy
T9	AdverseReaction 456 470	endocrinopathy
T10	Factor 1276 1279	can
T11	Severity 1290 1296	severe
T12	AdverseReaction 1301 1306	fatal
T13	AdverseReaction 1307 1340	immune-mediated adverse reactions
T14	Factor 122 125	can
T15	Factor 263 266	may
T16	Factor 1417 1420	may
T17	Severity 1472 1478	severe
T18	AdverseReaction 1479 1512	immune-mediated adverse reactions
T19	AdverseReaction 1517 1530	enterocolitis
T20	AdverseReaction 1532 1541	hepatitis
T21	AdverseReaction 1543 1553	dermatitis
T22	AdverseReaction 1565 1591	toxic epidermal necrolysis
T23	AdverseReaction 1594 1604	neuropathy
T24	AdverseReaction 1610 1624	endocrinopathy
T25	AdverseReaction 30 63	IMMUNE-MEDIATED ADVERSE REACTIONS
T26	AdverseReaction 76 109	IMMUNE-MEDIATED ADVERSE REACTIONS
T27	AdverseReaction 325 358	immune-mediated adverse reactions
T28	AdverseReaction 237 262	immune-mediated reactions
T29	Severity 318 324	severe
T30	AdverseReaction 1160 1193	IMMUNE-MEDIATED ADVERSE REACTIONS
T31	AdverseReaction 1648 1673	immune-mediated reactions
E1	AdverseReaction:T1 Effect:E3 Hypothetical:E14
E2	AdverseReaction:T2 Hypothetical:E14
E3	Severity:T3
E4	AdverseReaction:T4 Hypothetical:E15 Effect:E29
E5	AdverseReaction:T5 Hypothetical:E15 Effect:E29
E6	AdverseReaction:T6 Hypothetical:E15 Effect:E29
E7	AdverseReaction:T7 Hypothetical:E15 Effect:E29
E8	AdverseReaction:T8 Hypothetical:E15 Effect:E29
E9	AdverseReaction:T9 Hypothetical:E15 Effect:E29
E10	Factor:T10
E11	Severity:T11
E12	AdverseReaction:T12 Hypothetical:E10
E13	AdverseReaction:T13 Effect:E11 Hypothetical:E10
E14	Factor:T14
E15	Factor:T15
E16	Factor:T16
E17	Severity:T17
E18	AdverseReaction:T18 Effect:E17 Hypothetical:E16
E19	AdverseReaction:T19 Hypothetical:E16 Effect:E17
E20	AdverseReaction:T20 Hypothetical:E16 Effect:E17
E21	AdverseReaction:T21 Hypothetical:E16 Effect:E17
E22	AdverseReaction:T22 Hypothetical:E16 Effect:E17
E23	AdverseReaction:T23 Hypothetical:E16 Effect:E17
E24	AdverseReaction:T24 Hypothetical:E16 Effect:E17
E25	AdverseReaction:T25
E26	AdverseReaction:T26
E27	AdverseReaction:T27 Effect:E29
E28	AdverseReaction:T28
E29	Severity:T29
E30	AdverseReaction:T30
E31	AdverseReaction:T31
A1	CUI E1 C0020517
A2	UMLS-Preferred-Name E1 Hypersensitivity
A3	MEDDRA-PT E1 Hypersensitivity
A4	MEDDRA-PT-ID E1 10020751
A5	CUI E2 C1306577
A6	UMLS-Preferred-Name E2 Death (finding)
A7	MEDDRA-PT E2 Death
A8	MEDDRA-PT-ID E2 10011906
A9	CUI E4 C0014356
A10	UMLS-Preferred-Name E4 Enterocolitis
A11	MEDDRA-PT E4 Enterocolitis
A12	MEDDRA-PT-ID E4 10014893
A13	CUI E5 C0019158
A14	UMLS-Preferred-Name E5 Hepatitis
A15	MEDDRA-PT E5 Hepatitis
A16	MEDDRA-PT-ID E5 10019717
A17	CUI E6 C0011603
A18	UMLS-Preferred-Name E6 Dermatitis
A19	MEDDRA-PT E6 Dermatitis
A20	MEDDRA-PT-ID E6 10012431
A21	CUI E7 C0014518
A22	UMLS-Preferred-Name E7 Toxic Epidermal Necrolysis
A23	MEDDRA-PT E7 Toxic epidermal necrolysis
A24	MEDDRA-PT-ID E7 10044223
A25	CUI E8 C0442874
A26	UMLS-Preferred-Name E8 Neuropathy
A27	MEDDRA-PT E8 Neuropathy peripheral
A28	MEDDRA-PT-ID E8 10029331
A29	LLT E8 Neuropathy
A30	LLT-ID E8 10029328
A31	CUI E9 C0014130
A32	UMLS-Preferred-Name E9 Endocrine System Diseases
A33	MEDDRA-PT E9 Endocrine disorder
A34	MEDDRA-PT-ID E9 10014695
A35	CUI E12 C1306577
A36	UMLS-Preferred-Name E12 Death (finding)
A37	MEDDRA-PT E12 Death
A38	MEDDRA-PT-ID E12 10011906
A39	CUI E13 C0020517
A40	UMLS-Preferred-Name E13 Hypersensitivity
A41	MEDDRA-PT E13 Hypersensitivity
A42	MEDDRA-PT-ID E13 10020751
A43	CUI E18 C0020517
A44	UMLS-Preferred-Name E18 Hypersensitivity
A45	MEDDRA-PT E18 Hypersensitivity
A46	MEDDRA-PT-ID E18 10020751
A47	CUI E19 C0014356
A48	UMLS-Preferred-Name E19 Enterocolitis
A49	MEDDRA-PT E19 Enterocolitis
A50	MEDDRA-PT-ID E19 10014893
A51	CUI E20 C0019158
A52	UMLS-Preferred-Name E20 Hepatitis
A53	MEDDRA-PT E20 Hepatitis
A54	MEDDRA-PT-ID E20 10019717
A55	CUI E21 C0011603
A56	UMLS-Preferred-Name E21 Dermatitis
A57	MEDDRA-PT E21 Dermatitis
A58	MEDDRA-PT-ID E21 10012431
A59	CUI E22 C0014518
A60	UMLS-Preferred-Name E22 Toxic Epidermal Necrolysis
A61	MEDDRA-PT E22 Toxic epidermal necrolysis
A62	MEDDRA-PT-ID E22 10044223
A63	CUI E23 C0442874
A64	UMLS-Preferred-Name E23 Neuropathy
A65	MEDDRA-PT E23 Neuropathy peripheral
A66	MEDDRA-PT-ID E23 10029331
A67	LLT E23 Neuropathy
A68	LLT-ID E23 10029328
A69	CUI E24 C0014130
A70	UMLS-Preferred-Name E24 Endocrine System Diseases
A71	MEDDRA-PT E24 Endocrine disorder
A72	MEDDRA-PT-ID E24 10014695
A73	CUI E25 C0020517
A74	UMLS-Preferred-Name E25 Hypersensitivity
A75	MEDDRA-PT E25 Hypersensitivity
A76	MEDDRA-PT-ID E25 10020751
A77	CUI E26 C0020517
A78	UMLS-Preferred-Name E26 Hypersensitivity
A79	MEDDRA-PT E26 Hypersensitivity
A80	MEDDRA-PT-ID E26 10020751
A81	CUI E27 C0020517
A82	UMLS-Preferred-Name E27 Hypersensitivity
A83	MEDDRA-PT E27 Hypersensitivity
A84	MEDDRA-PT-ID E27 10020751
A85	CUI E28 C0020517
A86	UMLS-Preferred-Name E28 Hypersensitivity
A87	MEDDRA-PT E28 Hypersensitivity
A88	MEDDRA-PT-ID E28 10020751
A89	CUI E30 C0020517
A90	UMLS-Preferred-Name E30 Hypersensitivity
A91	MEDDRA-PT E30 Hypersensitivity
A92	MEDDRA-PT-ID E30 10020751
A93	CUI E31 C0020517
A94	UMLS-Preferred-Name E31 Hypersensitivity
A95	MEDDRA-PT E31 Hypersensitivity
A96	MEDDRA-PT-ID E31 10020751
